Sens. Order Medtronic To Turn Over Infuse Records

Law360, New York (June 22, 2011, 1:30 PM EDT) -- Sens. Max Baucus, D-Mont., and Chuck Grassley, R-Iowa, told Medtronic Inc. on Tuesday to produce records related to its bone growth product Infuse, citing concerns that researchers tied to the health giant failed to report serious side effects, including sterility.

Baucus, who chairs the Senate Finance Committee, and Grassley, its senior member, requested the records in a letter to Medtronic Chairman and CEO Omar Ishrak. The letter cited news reports suggesting that doctors paid by Medtronic either failed to report or underreported Infuse's side effects, such...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.